Time Trade-Off Health Utility Values for Depression: A Systematic Review
Author(s)
Balázs P1, Erdősi D2, Rencz F3, Zemplényi A4, Brodszky V5
1Corvinus University of Budapest, Doctoral School of Business and Management & Department of Health Economics, Budapest, Hungary, 2Semmelweis University, Budapest, Hungary, 3Corvinus University of Budapest, Department of Health Economics, Budapest, Hungary, 4University of Pécs, Faculty of Pharmacy, Division of Pharmacoeconomics, Pécs, Hungary, 5Corvinus University of Budapest, Department of Health Economics, Budapest, PE, Hungary
OBJECTIVES We aim to systematically review of all original articles assessing direct utilities in depression using time-trade off (TTO) method. METHODS A systematic literature review was conducted in November 2020 in four online databases (PubMed, Web of Science, Psychinfo and Cochrane Library). Search strategy was built up as combination of different spellings of TTO terms and “depression” keyword. Inclusion criteria were (1) original publications (2) eliciting TTO utility for depression. RESULTS Of the 264 records screened, 13 studies were included into the analysis. The first study was published in 1991 the latest in 2020. Eleven (n=85%) cross sectional, and two (n=15%) randomized/case-control trials were published. Sample sizes ranged between 32 and 3,986. Study sample consisted mostly of patients with depression (n=6) and general population (n=5), one study focused on health professionals and one had a combined population sample. The most common type of data collection was semi-structured interview (n=8), three studies applied paper-based self-completed questionnaires, and two collected data online by self-administrated surveys. Eleven studies (n=85%) followed a conventional TTO method. The most frequent timeframe was 10 years (n=6), while other studies set subjective life expectancy; 50 years; 80-year-old age; varying between 20-40 years; 10+10 years waiting time as a timeframe. Five out of six studies developed vignettes based on standardized scales: McSad scale (n=3), SF-12 and TooL questionnaire. Overall, 42 different utility values occurred across the 13 studies. Seven studies elicited 17 utility values for self-experienced depression, ranging from 0.24-0.93. Six publications measured 25 utility values for five different hypothetical depression health states. Utili of hypothetical states ranged as follows: mild depression 0.66-0.91; moderate depression 0.49-0.79; severe depression 0.31-0.65 respectively. CONCLUSIONS So far this is the first research that systematically compared vignettes describing depression health states and catalogued TTO utility values in depression to help further economic evaluations and guide reimbursement decision making.
Conference/Value in Health Info
2021-11, ISPOR Europe 2021, Copenhagen, Denmark
Value in Health, Volume 24, Issue 12, S2 (December 2021)
Code
POSA377
Topic
Patient-Centered Research
Topic Subcategory
Health State Utilities, Patient-reported Outcomes & Quality of Life Outcomes
Disease
Mental Health
Explore Related HEOR by Topic